Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition (Q38776127)

6 September 2017

title

Diabetes and disordered bone metabolism (diabetic osteodystrophy): time for recognition (English)

1 reference

6 September 2017

G Defeudis

2

0 references

Nicola Napoli

object named as

N Napoli

4

0 references

author name string

S Epstein

1

1 reference

6 September 2017

S Manfrini

3

1 reference

6 September 2017

P Pozzilli

5

1 reference

6 September 2017

Scientific Committee of the First International Symposium on Diabetes and Bone

6

1 reference

6 September 2017

language of work or name

English

0 references

publication date

15 March 2016

1 reference

Osteoporosis International

6 September 2017

published in

1 reference

6 September 2017

volume

27

1 reference

6 September 2017

issue

6

1 reference

6 September 2017

page(s)

1931-1951

1 reference

6 September 2017

cites work

Type 2 diabetes and bone

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Prevalence of multiple chronic conditions among Medicare beneficiaries, United States, 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Type 2 diabetes mellitus and fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Fracture risk in diabetic elderly men: the MrOS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Falls risk in older adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Life Expectancy in Patients Treated for Osteoporosis: Observational Cohort Study Using National Danish Prescription Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Stiffness of compact bone: effects of porosity and density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

In vivo assessment of bone quality in postmenopausal women with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Volumetric femoral BMD, bone geometry, and serum sclerostin levels differ between type 2 diabetic postmenopausal women with and without fragility fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Trabecular bone score as an indicator for skeletal deterioration in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Diabetes, fracture, and bone fragility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Advanced glycation end-products: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Pentosidine effects on human osteoblasts in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Advanced glycation endproducts interefere with integrin-mediated osteoblastic attachment to a type-I collagen matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Advanced glycation end-products attenuate human mesenchymal stem cells and prevent cognate differentiation into adipose tissue, cartilage, and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Unlocking the biology of RAGE in diabetic microvascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Glycation endproducts in osteoporosis--is there a pathophysiologic importance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Glucose-induced inhibition of in vitro bone mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Understanding the pathology and mechanisms of type I diabetic bone loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Weight loss, exercise, or both and physical function in obese older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Exercise training in obese older adults prevents increase in bone turnover and attenuates decrease in hip bone mineral density induced by weight loss despite decline in bone-active hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Possible adverse effects of SGLT2 inhibitors on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Serum and urinary markers of bone remodeling: assessment of bone turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Haversian bone formation rates determined by a new method in a mastodon, and in human diabetes mellitus and osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Trabecular bone histomorphometry in humans with Type 1 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Does vitamin D play a significant role in type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Vitamin D and diabetes: Where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Vitamin D, muscle and bone: Integrating effects in development, aging and injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Calciotrophic hormones and hyperglycemia modulate vitamin D receptor and 25 hydroxyy vitamin D 1-α hydroxylase mRNA expression in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Renal replacement therapy in Europe: a summary of the 2011 ERA-EDTA Registry Annual Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Pancreas-kidney transplantation is associated with reduced fracture risk compared with kidney-alone transplantation in men with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Effect of transient post-transplantation hyperglycemia on the development of diabetes mellitus and transplantation outcomes in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Diabetes mellitus and renal transplantation in adults: is there enough evidence for diagnosis, treatment, and prevention of new-onset diabetes after renal transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Impact of pre-transplant dialysis modality on post-transplant diabetes mellitus after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Risk factors and consequences of post-transplant diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

New-onset diabetes after transplantation: assessment of risk factors and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Single-dose rATG induction at renal transplantation: superior renal function and glucoregulation with less hypomagnesemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

The PROMISE study: a phase 2b multicenter study of voclosporin (ISA247) versus tacrolimus in de novo kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

New-onset diabetes mellitus after kidney transplantation: the role of immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Prediction at first year of incident new-onset diabetes after kidney transplantation by risk prediction models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

New-onset diabetes after transplantation: drug-related risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Playing with bone and fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Regulation of Wnt signaling during adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

WNT signaling in bone homeostasis and disease: from human mutations to treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Sequential roles of Hedgehog and Wnt signaling in osteoblast development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Mechanisms of anabolic therapies for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Role of sclerostin in the bone loss of postmenopausal chinese women with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Bone and mineral metabolism in patients undergoing Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Inhibition of food intake in obese subjects by peptide YY3-36

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Attenuated peptide YY release in obese subjects is associated with reduced satiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

The gut hormone peptide YY regulates appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Elevated peptide YY levels in adolescent girls with anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Hypothalamic Y2 receptors regulate bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Peptide YY regulates bone turnover in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

GIP and bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Effect of ghrelin on bone mass density: the InChianti study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Stimulation of intramembranous bone repair in rats by ghrelin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Ghrelin directly regulates bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Ghrelin regulates proliferation and differentiation of osteoblastic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Inhibitory effect of amylin on basal and parathyroid hormone-stimulated bone resorption in cultured neonatal mouse calvaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Amylin in bone conservation current evidence and hypothetical Considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Insulin stimulates osteoblast proliferation and differentiation through ERK and PI3K in MG-63 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Aseptic loosening of pedicle screw as a result of metal wear debris in a pediatric patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Weight Loss After RYGB Is Independent of and Complementary to Serotonin 2C Receptor Signaling in Male Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Leptin deficiency produces contrasting phenotypes in bones of the limb and spine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Why does starvation make bones fat?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

What's the matter with MAT? Marrow adipose tissue, metabolism, and skeletal health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Changes in vertebral bone marrow fat and bone mass after gastric bypass surgery: A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Effect of voluntary weight loss on bone mineral density in older overweight women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Intentional and unintentional weight loss increase bone loss and hip fracture risk in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Effect of weight loss and exercise therapy on bone metabolism and mass in obese older adults: a one-year randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Voluntary weight reduction in older men increases hip bone loss: the osteoporotic fractures in men study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Increasing adiposity is associated with higher adipokine levels and lower bone mineral density in obese older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Relationship of obesity with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Inducible brown adipose tissue, or beige fat, is anabolic for the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Marrow fat and bone--new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

The role of bone marrow and visceral fat on bone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Bone and muscle loss after spinal cord injury: organ interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Increased bone marrow fat in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Bone marrow changes in adolescent girls with anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Increased marrow adiposity in premenopausal women with idiopathic osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Bone acquisition in healthy young females is reciprocally related to marrow adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Reciprocal relation between marrow adiposity and the amount of bone in the axial and appendicular skeleton of young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Bone Marrow Fat Is Inversely Related to Cortical Bone in Young and Old Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

MRI-measured pelvic bone marrow adipose tissue is inversely related to DXA-measured bone mineral in younger and older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

IGF-1 and IGF-binding proteins and bone mass, geometry, and strength: relation to metabolic control in adolescent girls with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Understanding the Skeletal Pathology of Type 1 and 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Does vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, and blood biomarkers in women with type 2 diabetes mellitus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

In vitro and in vivo effects of adiponectin on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Serum adiponectin and bone mineral density in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Adiponectin and bone mass density: The InCHIANTI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Resistin release by human adipose tissue explants in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Insulin resistance and chronic cardiovascular inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Is obesity an inflammatory condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Interleukin-6 and diabetes: the good, the bad, or the indifferent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

The interleukin 6-174G/C polymorphism is associated with indices of obesity in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Interleukin-6: An osteotropic factor influencing bone formation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Radicals and oxidative stress in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

How metabolic acidosis and oxidative stress alone and interacting may increase the risk of fracture in diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Estrogen production and action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Effect of estrogens on bone marrow adipogenesis and Sirt1 in aging C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Trabecular bone score: a noninvasive analytical method based upon the DXA image

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Bone histomorphometry: a concise review for endocrinologists and clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

In vivo ultra-high-field magnetic resonance imaging of trabecular bone microarchitecture at 7 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: applications in the study of human trabecular bone microarchitecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Evaluation of the potential use of trabecular bone score to complement bone mineral density in the diagnosis of osteoporosis: a preliminary spine BMD-matched, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Trabecular bone score (TBS): available knowledge, clinical relevance, and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Human trabecular bone microarchitecture can be assessed independently of density with second generation HR-pQCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Variability in reference point microindentation and recommendations for testing cortical bone: location, thickness and orientation heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Bone and kidney disease: diagnostic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Associations between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Diabetes reduces mesenchymal stem cells in fracture healing through a TNFα-mediated mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Diabetes and fractures: an overshadowed association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

TNF-alpha mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Chemokine expression is upregulated in chondrocytes in diabetic fracture healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Mesenchymal stem cells as trophic mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Normal blood flow response and vasomotion in the diabetic Charcot foot

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

The Sirtuin1 activator SRT3025 down-regulates sclerostin and rescues ovariectomy-induced bone loss and biomechanical deterioration in female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

TBS (Trabecular Bone Score) and Diabetes-Related Fracture Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Leptin Inhibits Osteoclast Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00198-015-3454-X

Synthesis and evaluation of disulfide bond mimetics of amylin-(1–8) as agents to treat osteoporosis

21 January 2018

1 reference

12 December 2020

Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism

1 reference

12 December 2020

Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae

1 reference

12 December 2020

Bone health in type 1 diabetes: focus on evaluation and treatment in clinical practice

1 reference

12 December 2020

Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice

1 reference

12 December 2020

Association between bone indices assessed by DXA, HR-pQCT and QCT scans in post-menopausal women

1 reference

12 December 2020

Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways

1 reference

12 December 2020

Alterations of the Wnt/β-catenin pathway and its target genes for the N- and C-terminal domains of parathyroid hormone-related protein in bone from diabetic mice

1 reference

12 December 2020

Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast

1 reference

12 December 2020

Leptin reduces ovariectomy-induced bone loss in rats

1 reference

12 December 2020

[Histomorphometric analysis of the bone tissue in patients with non-insulin-dependent diabetes (DMNID)]

1 reference

12 December 2020

Insulin receptor expression in primary and cultured osteoclast-like cells

1 reference

12 December 2020

The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis

1 reference

12 December 2020

Risk factors and outcomes of new-onset diabetes after transplant: single-centre experience

1 reference

12 December 2020

Corrigendum to "SGLT2 inhibitor therapy improves blood glucose but does not prevent diabetic bone disease in diabetic DBA/2J male mice" [Bone 82 (2016) 101-107]

1 reference

12 December 2020

Mycophenolate mofetil: a promising new immunosuppressant that does not cause bone loss in the rat

1 reference

12 December 2020

New onset of diabetes after transplantation is associated with improved patient survival after liver transplantation due to confounding factor

1 reference

12 December 2020

New-onset diabetes after liver transplantation and its impact on complications and patient survival

1 reference

12 December 2020

Site-Dependent Reference Point Microindentation Complements Clinical Measures for Improved Fracture Risk Assessment at the Human Femoral Neck.

1 reference

12 December 2020

Biochemical bone turnover markers in diabetes mellitus - A systematic review

1 reference

12 December 2020

Effects of amylin on human osteoblast-like cells

1 reference

12 December 2020

Adipose tissue, estradiol levels, and bone health in obese men with metabolic syndrome

1 reference

12 December 2020

Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy?

1 reference

12 December 2020

Oxidative stress in diabetes.

1 reference

12 December 2020

Vitamin D replacement and type 2 diabetes mellitus.

1 reference

12 December 2020

Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors

1 reference

12 December 2020

The alliance of mesenchymal stem cells, bone, and diabetes

1 reference

12 December 2020

Osteopenia, neurological dysfunction, and the development of Charcot neuroarthropathy

1 reference

12 December 2020

Predictive Value of BMD for Hip and Other Fractures

1 reference

12 December 2020

An overview of the metabolic functions of osteocalcin

1 reference

12 December 2020

Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways

1 reference

12 December 2020

Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage.

1 reference

12 December 2020

Exposure to hydrogen peroxide diminishes NF-kappaB activation, IkappaB-alpha degradation, and proteasome activity in neutrophils

1 reference

12 December 2020

New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression

1 reference

12 December 2020

Ghrelin? Yes, it is spelled correctly

1 reference

12 December 2020

Effects of glucose-dependent insulinotropic peptide on osteoclast function

1 reference

12 December 2020

New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003.

1 reference

12 December 2020

Are antiresorptive drugs effective against fractures in patients with diabetes?

1 reference

12 December 2020

Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover

1 reference

12 December 2020

10.1007/S00198-015-3454-X

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1011549949

0 references

1 reference